ICER 2023: Circular targets remain out of reach The Netherlands aims to have a fully circular economy by 2050 and halve its use of raw materials by 2030. In recent years, however, little progress has been made in either regard.
RIVM describes building blocks of future-proof soil strategy Soil use is becoming increasingly intensive. From use for agriculture and housing construction to recreation and infrastructure. At the same time, we also depend on the soil-watersystem for a healthy living environment, restore biodiversity, countering climate change, energy transition, absorption of rainwater and keeping groundwater clean.
Vaccination coverage for autumn round: Downward trend in Health & Welfare sector continues – 69% of nationwide medical high-risk groups were vaccinated At the start of the autumn round, from mid-September 2022, the first group to be offered a repeat vaccination against COVID-19 was people with an elevated risk of a severe course of illness and care workers who have contact with patients and/or clients
Urgent need for more research into environmental effects of microplastics Additional solutions are urgently needed to limit emissions of microplastics into the environment. Growing quantities of microplastics (particles of 5 mm or less) are entering our living environment every day.
Circular economy: plastics recycling from end-of-life vehicles could be four times higher At present, 85% of plastics from end-of-life vehicles is still incinerated. Only 15% of plastics is reused as a raw material. A survey conducted by RIVM has revealed possibilities to expand recovery of these plastics fourfold by 2030.
Proposed European PFAS ban officially submitted The Netherlands, Germany, Denmark, Sweden and Norway today took the first formal step towards a European ban on per- and polyfluoroalkyl substances (PFAS) by jointly submitting a restriction proposal to the European Chemicals Agency (ECHA).
More than two million invitations to get vaccinated against HPV in 2023 In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.
Joint Action CHRODIS PLUS: RIVM’s contribution to strengthening Health Promotion Within the Joint Action for the prevention and treatment of chronic diseases CHRODIS PLUS, RIVM has developed a set of recommendations for intersectoral cooperation to strengthen health promotion a
Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.
Preparations for COVID-19 vaccinations now in progress RIVM is preparing for implementation of the coronavirus vaccinations. As soon as there is a safe and effective vaccine against the novel coronavirus, it will be quickly and carefully deployed to vaccinate the target groups.